Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common stock ("Common Shares")
-
Shares outstanding
-
212,883,456
-
Number of holders
-
137
-
Total 13F shares, excl. options
-
44,501,826
-
Shares change
-
-3,826,757
-
Total reported value, excl. options
-
$445,218,082
-
Value change
-
-$45,732,043
-
Put/Call ratio
-
59%
-
Number of buys
-
61
-
Number of sells
-
69
-
Price
-
$10.00
Institutional Holders of OCULAR THERAPEUTIX, INC - Common stock ("Common Shares") (OCUL) as of Q3 2021
As of 30 Sep 2021 OCULAR THERAPEUTIX, INC - Common stock ("Common Shares") (OCUL) had 137 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 44,501,826 shares of stock of the company.
Largest 10 holders included Opaleye Management Inc., SUMMER ROAD LLC, BlackRock Inc., VANGUARD GROUP INC, DELTEC ASSET MANAGEMENT LLC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, FMR LLC, TWO SIGMA ADVISERS, LP, and TWO SIGMA INVESTMENTS, LP.
This table shows 137 institutional shareholders of the security as of 30 Sep 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.